Brice Foose - 05 Feb 2023 Form 4 Insider Report for INVIVO THERAPEUTICS HOLDINGS CORP.

Role
10%+ Owner
Signature
Brice Foose
Issuer symbol
N/A
Transactions as of
05 Feb 2023
Net transactions value
-$123,030
Form type
4
Filing time
07 Feb 2024, 13:31:40 UTC
Next filing
24 Apr 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction NVIV InVivo Therapeutics Holdings Corp Purchase $11,470 -37,000 -11% $0.3100 293,000 05 Feb 2023 Direct
transaction NVIV InVivo Therapeutics Holdings Corp Purchase $6,400 -20,000 -6.8% $0.3200 273,000 05 Feb 2023 Direct
transaction NVIV InVivo Therapeutics Holdings Corp Purchase $3,900 -13,000 -4.8% $0.3000 260,000 05 Feb 2023 Direct
transaction NVIV InVivo Therapeutics Holdings Corp Purchase $13,440 -48,000 -18% $0.2800 212,000 05 Feb 2023 Direct
transaction NVIV InVivo Therapeutics Holdings Corp Purchase $3,000 -12,000 -5.7% $0.2500 200,000 05 Feb 2023 Direct
transaction NVIV InVivo Therapeutics Holdings Corp Purchase $9,360 -36,000 -18% $0.2600 164,000 05 Feb 2023 Direct
transaction NVIV InVivo Therapeutics Holdings Corp Purchase $2,720 -8,000 -4.9% $0.3400 156,000 06 Feb 2023 Direct
transaction NVIV InVivo Therapeutics Holdings Corp Purchase $11,550 -33,000 -21% $0.3500 123,000 06 Feb 2023 Direct
transaction NVIV InVivo Therapeutics Holdings Corp Purchase $12,600 -35,000 -28% $0.3600 88,000 06 Feb 2023 Direct
transaction NVIV InVivo Therapeutics Holdings Corp Purchase $18,500 -37,000 -42% $0.5000 51,000 06 Feb 2023 Direct
transaction NVIV InVivo Therapeutics Holdings Corp Purchase $30,090 -51,000 -100% $0.5900 0 06 Feb 2023 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.